Quality of life after nivolumab treatment for head and neck cancer

被引：4
作者：
Singer, Susanne [1 ]
机构：
[1] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Div Epidemiol & Hlth Serv Res, D-55131 Mainz, Germany
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 08期
关键词：
SQUAMOUS-CELL CARCINOMA; EORTC QLQ-H-AND-N35; RECURRENT; THERAPY; UPDATE; MODULE;
D O I：
10.1016/S1470-2045(17)30463-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：993 / +
页数：3
相关论文
共 50 条
[21]   Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab [J].
Schwab, Katjana S. ;
Kristiansen, Glenn ;
Schild, Hans H. ;
Held, Stefanie E. A. ;
Heine, Annkristin ;
Brossart, Peter .
CASE REPORTS IN ONCOLOGY, 2018, 11 (01) :17-20
[22]   The impact of treatment on quality of life of patients with head and neck cancer and its association with prognosis [J].
Carrillo, J. F. ;
Carrillo, L. C. ;
Ramirez-Ortega, M. C. ;
Ochoa-Carrillo, F. J. ;
Onate-Ocana, L. F. .
EJSO, 2016, 42 (10) :1614-1621
[23]   Quality of Life in Head and Neck Cancer Patients: Impact of HPV and Primary Treatment Modality [J].
Maxwell, Jessica H. ;
Mehta, Vikas ;
Wang, Hong ;
Cunningham, Diana ;
Duvvuri, Umamaheswar ;
Kim, Seungwon ;
Johnson, Jonas T. ;
Ferris, Robert L. .
LARYNGOSCOPE, 2014, 124 (07) :1592-1597
[24]   Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma [J].
Fushimi, Chihiro ;
Okamoto, Isaku ;
Matsuki, Takashi ;
Masubuchi, Tatsuo ;
Okada, Takuro ;
Sato, Hiroki ;
Tsukahara, Kiyoaki ;
Kondo, Takahito ;
Yamashita, Taku ;
Hanyu, Kenji ;
Omura, Go ;
Takahashi, Hideaki ;
Tada, Yuichiro ;
Miura, Kouki .
ANTICANCER RESEARCH, 2020, 40 (09) :5277-5283
[25]   Quality of life after treatment of head and neck tumors. Longitudinal comparison after operation and adjuvant radio(chemo)therapy [J].
Buecheler, B. M. ;
Ehnes, A. ;
Kavsadze, M. ;
Langenberg, S. ;
Wilhelm-Buchstab, T. ;
Zipfel, M. ;
Keiner, S. ;
Gerstner, A. O. H. .
HNO, 2012, 60 (12) :1053-1059
[26]   The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial [J].
Botticelli, Andrea ;
Mezi, Silvia ;
Pomati, Giulia ;
Sciattella, Paolo ;
Cerbelli, Bruna ;
Roberto, Michela ;
Mammone, Giulia ;
Cirillo, Alessio ;
Cassano, Alessandra ;
Di Dio, Carmela ;
Cortellini, Alessio ;
Pizzuti, Laura ;
Ronzino, Graziana ;
Salati, Massimiliano ;
Vici, Patrizia ;
Polimeni, Antonella ;
Merlano, Marco Carlo ;
Nuti, Marianna ;
Marchetti, Paolo .
VACCINES, 2020, 8 (02)
[27]   Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer [J].
Ward, Matthew C. ;
Shah, Chirag ;
Adelstein, David J. ;
Geiger, Jessica L. ;
Miller, Jacob A. ;
Koyfman, Shlomo A. ;
Singer, Mendel E. .
ORAL ONCOLOGY, 2017, 74 :49-55
[28]   Treatment strategy after the discontinuation of immunotherapy for head and neck cancer: a review [J].
Wakasugi, Tetsuro .
JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9
[29]   Assessment of quality of life among head and neck cancer patients [J].
Rafie, Forouzan ;
Torabi, Molook ;
Taheri, Ali ;
Mellat, Zahra .
JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2020, 6 (01) :17-21
[30]   Identity Processing Styles and Quality of Life in Head and Neck Cancer [J].
Khan, Kaleem ;
Pelletier, Guy .
CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT, 2021, 53 (03) :243-253
12345